Blend Labs (BLND) accounting chief sells 5,625 shares under 10b5-1 plan

Rhea-AI Filing Summary

Blend Labs principal accounting officer Oxana Tkach sold 5,625 shares of Class A common stock in an open-market transaction under a prearranged Rule 10b5-1 trading plan. The shares were sold at a weighted average price of about $1.59 per share, within a range of $1.57 to $1.63, leaving her with 96,238 shares directly owned after the sale.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Tkach Oxana

(Last) (First) (Middle)

7250 REDWOOD BLVD., SUITE 300

(Street)

NOVATO CA 94945

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Blend Labs, Inc. [ BLND ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	PRINCIPAL ACCOUNTING OFFICER

3. Date of Earliest Transaction (Month/Day/Year)
02/24/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	02/24/2026		S(1)		5,625	D	$1.592(2)	96,238	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 9, 2025.

2. This sale price represents the weighted average sale price of the shares sold ranging from $1.57 to $1.63 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

	/s/ Kostian Ciko, Attorney-in-fact	02/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Blend Labs (BLND) report for Oxana Tkach?

Blend Labs reported that principal accounting officer Oxana Tkach sold 5,625 shares of Class A common stock. The sale was executed in the open market under a prearranged Rule 10b5-1 trading plan covering these transactions.

At what price did Oxana Tkach sell Blend Labs (BLND) shares?

The reported sale used a weighted average price of approximately $1.59 per share. Individual trades occurred in a price range from $1.57 to $1.63 per share, with detailed breakdowns available upon request from the reporting person.

How many Blend Labs (BLND) shares does Oxana Tkach hold after this sale?

After selling 5,625 shares, Oxana Tkach directly owns 96,238 shares of Blend Labs Class A common stock. This remaining balance reflects her direct holdings immediately following the reported open-market transaction.

Was the Blend Labs (BLND) insider sale by Oxana Tkach under a 10b5-1 plan?

Yes, the sale was carried out under a Rule 10b5-1 trading plan adopted by Oxana Tkach. Such plans allow insiders to prearrange trades, helping separate routine portfolio management from future information about the company.

What does the price range in Oxana Tkach’s Blend Labs (BLND) sale mean?

The filing shows a weighted average sale price with trades between $1.57 and $1.63 per share. The insider notes that full details of shares sold at each specific price within this range are available upon request to interested parties.